ISRG · Earnings call · 2026Q3T · Full report

Pricing and Access Expansion

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 34 · Surprise 42

Intuitive finalized pricing actions for a subset of high-volume benign procedures where cost may constrain access, aiming to broaden adoption and reach more patients. Beginning in the first half of 2027, the company plans to extend the useful lives of selected EndoWrist instruments on fourth- and fifth-generation platforms and introduce volume-based pricing. Management identified cholecystectomy and inguinal hernia repair as target procedures, particularly outside the U.S. and in ambulatory settings. The actions, together with XiR availability, are expected to reduce da Vinci instrument-and-accessory revenue per procedure by approximately 3% to 5% on a mix-constant basis once fully implemented.

Key facts